
About Zevra
Zevra is a publicly listed company based in Celebration (United States) founded in 2006 by Christal MM Mickle. Marketing services are provided to biopharma companies. The company has 59 employees. Zevra has completed 1 acquisition, including Acer Therapeutics. Its chief executive, as recorded, is Neil F McFarlane. Zevra offers products and services including MIPLYFFA, OLPRUVA, and AZSTARYS. Its focus areas include Biopharma Outsourcing and Marketing Services. Its legal entity is Zevra Therapeutics, Inc. Its competitors include Supreme Optimization, Woodward Pharma Services and CMI Media Group.
Company details
Zevra was established in 2006 in Celebration, United States, as a provider of marketing services focused on the biopharma sector. Operations center on supporting pharmaceutical and biotechnology firms through targeted marketing strategies. Services include promotional campaigns, market analysis, and communication tools tailored to industry needs. The company is led by co-founder Christal MM Mickle and CEO Neil F McFarlane, with activities conducted primarily in the U.S. market.
- Annual Revenue$106.47 M (USD)350.91as on Dec 31, 2025
- Net Profit$77.58 M (USD)as on Dec 31, 2025
- EBITDA-$179 K (USD)99.78as on Dec 31, 2025
- Employee Count59
- Investments & Acquisitions
Products & Services of Zevra
Zevra offers a comprehensive portfolio of products and services, including MIPLYFFA, OLPRUVA, and AZSTARYS.
Treats specific rare diseases through targeted therapy approaches.
Addresses unmet needs in rare metabolic disorders effectively.
Focuses on neurological conditions with innovative treatment methods.
People of Zevra
29 people are tracked at Zevra (24 in leadership, 5 in team); the tracked headcount is 59.
| Name | Role | Group |
|---|---|---|
Christal MM Mickle | Co-Founder | Leadership |
Neil F McFarlane | CEO | Leadership |
Lauren Hitchins | Director, Strategic Operations And Medical Excellence | Leadership |
David Rowe Wood | Head Of Field Medical Affairs | Leadership |
Adrian Quartel | Chief Medical Officer | Leadership |
Timothy Sangiovanni | Senior Vice President, Corporate Controller | Leadership |
Rene A. Braeckman | Senior Vice President, Clinical Development | Leadership |
Laduane Clifton | Chief Financial Officer, Secretary And Treasurer | Leadership |
R. Laduane Clifton | Chief Financial Officer, Secretary, & Treasurer | Leadership |
Christopher M. Lauderback | Senior Vice President, Manufacturing | Leadership |
Adam Smith | Vice President, Business Development And Commercial Operations | Leadership |
Louise Himmelstrup | Vice President EU Regulatory Affairs | Leadership |
Sven Guenther | Chief Scientific Officer | Leadership |
Sanjib Bera | VP Drug Discovery | Leadership |
Abbi M. | Vp, Legal Affairs | Leadership |
Douglas Commerce | Sr. Director, CMC Quality Assurance | Leadership |
Tanya Hayden | Senior Vice President, Chief Of Staff | Leadership |
Mark Meier | Sr. Director, Marketing | Leadership |
Nichol Ochsner | Vice President, Investor Relations And Corporate Communications | Leadership |
Corinna Wetzel | Senior Director Product Development | Leadership |
9 more people are available in the full profile.
Complete people profiles for Zevra
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Zevra
Zevra is a publicly listed company on the NASDAQ with ticker symbol ZVRA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date16 Apr 2015
- Listed onNASDAQ: ZVRA
- Listed entityZevra Therapeutics, Inc.
- Exchange sectorHealth technology
- ISINUS4884452065
- Share price$10.39 (-8.22% on the day) · 2026-10-13
- Market capitalisation$617.0M
- Price to earnings11.2
- EPS (diluted, trailing year)$0.93
- Volume (last session)1,090,678
Financials of Zevra
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $106.5M | $77.6M | -$179,000 |
| 2024 | $23.6M | -$105.5M | -$80.6M |
| 2023 | $27.5M | -$46.0M | -$48.6M |
| 2022 | $10.2M | -$26.8M | -$24.0M |
| 2021 | $28.6M | -$8.6M | $8.0M |
Detailed financial statements for Zevra
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zevra
Zevra has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Acer Therapeutics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Treatments for ultra-rare diseases like vEDS and MSUD are developed. | acertx.com | Cambridge, United States | 1991 | Nov 2023 | •••• |
Complete acquisition details for Zevra
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Zevra
3 dated milestones of Zevra across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Zevra is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Acer Therapeutics.
Competitors of Zevra
Zevra has 3 listed competitors in our database. They include Supreme Optimization, Woodward Pharma Services and CMI Media Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| supremeopti.com | 2012 | San Juan, Puerto Rico | Digital marketing services are offered to the life sciences sector. | |||
| woodwardpharma.com | 2015 | Wixom, United States | Pharmaceutical company that provides outsourced marketing, sales, and commercial services for pharmaceutical companies | |||
| cmimediagroup.com | 1989 | Cherry Hill, United States | Full-service media agency is operated for healthcare and pharmaceutical marketing. |
Detailed competitors of Zevra
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Zevra
The website of Zevra (zevra.com) receives about 8K visits a month.
- Monthly visits8K
▲ 9.4% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Zevra (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zevra
Complete news archive for Zevra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zevra
Zevra was founded in 2006.
Zevra is headquartered in Celebration, United States. It is registered at Celebration, Florida, United States.
Neil F McFarlane is the CEO of Zevra, as recorded in our data.
Zevra has 59 employees.
Annual revenue of Zevra is $106.47M as on Dec 31, 2025.
Zevra was established in 2006 in Celebration, United States, as a provider of marketing services focused on the biopharma sector. Operations center on supporting pharmaceutical and biotechnology firms through targeted marketing strategies. Services include promotional campaigns, market analysis, and communication tools tailored to industry needs. The company is led by co-founder Christal MM Mickle and CEO Neil F McFarlane, with activities conducted primarily in the U.S. market.
Zevra's top competitors include CMI Media Group, Supreme Optimization and Woodward Pharma Services.
Zevra offers MIPLYFFA, OLPRUVA, and AZSTARYS.
Yes, Zevra is publicly traded on NASDAQ under the ticker symbol ZVRA.
Zevra has made 1 acquisition, including Acer Therapeutics.
Zevra operates through Zevra Therapeutics, Inc..
